Bridgeway Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-65,900	Closed	-$21.5K	–	1451
2023 Q2	$21.5K	Hold	65,900	–	–	﹤0.01%	1361
2023 Q1	$28.3K	Sell	65,900 -50,000	-43%	-$21.5K	﹤0.01%	1346
2022 Q4	$61.4K	Hold	115,900	–	–	﹤0.01%	1280
2022 Q3	$85K	Sell	115,900 -50,000	-30%	-$36.7K	﹤0.01%	1303
2022 Q2	$189K	Sell	165,900 -10,000	-6%	-$11.4K	﹤0.01%	1102
2022 Q1	$361K	Sell	175,900 -21,700	-11%	-$44.5K	0.01%	1021
2021 Q4	$569K	Sell	197,600 -50,000	-20%	-$144K	0.01%	943
2021 Q3	$1.05M	Buy	247,600 +98,000	+66%	+$416K	0.02%	810
2021 Q2	$791K	Buy	149,600 +12,200	+9%	+$64.5K	0.01%	933
2021 Q1	$639K	Hold	137,400	–	–	0.01%	1028
2020 Q4	$453K	Buy	137,400 +34,500	+34%	+$114K	0.01%	983
2020 Q3	$341K	Sell	102,900 -16,300	-14%	-$54K	0.01%	1018
2020 Q2	$402K	Buy	119,200 +75,500	+173%	+$255K	0.01%	931
2020 Q1	$167K	Sell	43,700 -50,000	-53%	-$191K	﹤0.01%	1106
2019 Q4	$566K	Buy	93,700 +13,200	+16%	+$79.7K	0.01%	924
2019 Q3	$609K	Hold	80,500	–	–	0.01%	871
2019 Q2	$1.09M	Hold	80,500	–	–	0.01%	710
2019 Q1	$436K	Buy	80,500 +25,000	+45%	+$135K	0.01%	1060
2018 Q4	$165K	Hold	55,500	–	–	﹤0.01%	1248
2018 Q3	$453K	Hold	55,500	–	–	﹤0.01%	1167
2018 Q2	$541K	Buy	55,500 +6,500	+13%	+$63.4K	0.01%	1109
2018 Q1	$426K	Hold	49,000	–	–	﹤0.01%	1134
2017 Q4	$613K	Hold	49,000	–	–	0.01%	1033
2017 Q3	$410K	Hold	49,000	–	–	﹤0.01%	1141
2017 Q2	$832K	Hold	49,000	–	–	0.01%	895
2017 Q1	$985K	Sell	49,000 -9,000	-16%	-$181K	0.01%	822
2016 Q4	$904K	Hold	58,000	–	–	0.01%	860
2016 Q3	$757K	Buy	+58,000	New	+$757K	0.01%	912